An unique exonic splicing mutation in the CYPI7AI gene as the cause of steroid 17α-hydroxylase deficiency

Background :1 7a-Hydroxylase/17,20-lyase deficiency (17OHD) caused by a mutation in the CYP17A1 gene is characterized by hypertension, hypokalemia, and abnormal development of the genitalia. The majority of CYP17A1 mutations are located in the coding sequence, and several intronic splicing site mutations have been reported. Objective: A 2.5-year-old girl with 46,XY disordered sex development exhibited a nearly normal basal cortisol level and reduced sexual steroids. This study is aimed to explore the molecular basis and analyze its possible influence on the phenotype of the patient. Methods and results: Mutation analysis revealed compound heterozygous CYP17A1 mutations, with c.985_987delinsAA in one allele and a synonymous substitution (c.1263GOA) in another allele. In vitro expression analysis of the allelic minigene showed that the novel nucleotide variation located in exon 8 induces a splicing signal, which results in an aberrant splicing of CYP17A1 mRNA and a missing portion of exon 8. The translation product includes the deletion of six or seven amino acids from residue position 415 without causing a frameshift. Consistent with the result of molecular modeling, functional studies in transiently transfected HEK-293T cells with the aberrantly spliced enzyme proteins showed that the deleted proteins completely abolished the enzyme activity. However, RT-PCR indicated the existence of a small fraction of normal, functionally intact enzyme, which may explain the partial masculinization of this patient. Conclusion: This is the first description of an exonic splicing mutation in CYP17A1 relevant to the 17OHD phenotype. It also demonstrates the importance of studying synonymous change in such patients with less severe phenotype.

[1]  Bing-Li Liu,et al.  Identification of steroid biosynthetic defects in genotype‐proven heterozygous individuals for 17α‐hydroxylase/17,20‐lyase deficiency , 2010, Clinical endocrinology.

[2]  J. Grötzinger,et al.  Steroid 17alpha-hydroxylase deficiency: functional characterization of four mutations (A174E, V178D, R440C, L465P) in the CYP17A1 gene. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  R. Auchus,et al.  Puberty in a case with novel 17-hydroxylase mutation and the putative role of estrogen in development of pubic hair. , 2008, European journal of endocrinology.

[4]  B Rosner,et al.  Determination of blood pressure percentiles in normal-weight children: some methodological issues. , 2008, American journal of epidemiology.

[5]  Z. Hochberg,et al.  Metabolic evidence for impaired 17alpha-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity. , 2008, European journal of endocrinology.

[6]  Q. Tian,et al.  Partial 17alpha-hydroxylase/17,20-lyase deficiency–clinical report of five Chinese 46,XX cases , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[7]  G. Balercia,et al.  P450c17 deficiency: clinical and molecular characterization of six patients. , 2007, The Journal of clinical endocrinology and metabolism.

[8]  Fengxiang Wei,et al.  Genotyping of five chinese patients with 17alpha-hydroxylase deficiency diagnosed through high-performance liquid chromatography serum adrenal profile: identification of two novel CYP17 mutations. , 2006, The Journal of clinical endocrinology and metabolism.

[9]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[10]  R. Auchus,et al.  Two intronic mutations cause 17-hydroxylase deficiency by disrupting splice acceptor sites: direct demonstration of aberrant splicing and absent enzyme activity by expression of the entire CYP17 gene in HEK-293 cells. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  Huai-Dong Song,et al.  A complex heterozygous mutation of His373Leu and Asp487–Ser488–Phe489 deletion in human cytochrome P450c17 causes 17α-hydroxylase/17,20-lyase deficiency in three Chinese sisters , 2003, Molecular and Cellular Endocrinology.

[12]  K. Choy,et al.  Mutation of proline 409 to arginine in the meander region of cytochrome p450c17 causes severe 17 alpha-hydroxylase deficiency. , 2001, Molecular genetics and metabolism.

[13]  M. Waterman,et al.  An Additional Electrostatic Interaction between Adrenodoxin and P450c27 (CYP27A1) Results in Tighter Binding Than between Adrenodoxin and P450scc (CYP11A1)* , 1999, The Journal of Biological Chemistry.

[14]  M. Nakazato,et al.  Identification of a novel splicing mutation and 1-bp deletion in the 17α-hydroxylase gene of Japanese patients with 17α-hydroxylase deficiency , 1998, Human Genetics.

[15]  M. Nakazato,et al.  A 5′-Splice Site Mutation in the Cytochrome P450 Steroid 17α-Hydroxylase Gene in 17α-Hydroxylase Deficiency , 1997 .

[16]  H. Sasano,et al.  Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17. , 1996, The Journal of clinical endocrinology and metabolism.

[17]  M. Waterman,et al.  Localization of the human CYP17 gene (cytochrome P450(17 alpha)) to 10q24.3 by fluorescence in situ hybridization and simultaneous chromosome banding. , 1992, Genomics.

[18]  M. Waterman,et al.  17α-Hydroxylase/17,20-Lyase Deficiency: From Clinical Investigation to Molecular Definition* , 1991 .

[19]  T. Mohandas,et al.  ASSIGNMENT OF THE GENE FOR ADRENAL P450cl7 (STEROID 17α-HYDR0XYLASE⁄17,20 LYASE) TO HUMAN CHROMOSOME 10. , 1986 .